Skip to main content
All lobbying filings

THE MCMANUS GROUP

Lobbying for ZIMMER BIOMET · A global leader in musculoskeletal healthcare.

 Filing 3rd Quarter - Report
3rd Quarter (July 1 - Sep 30) 2025 · Indiana · House · Senate · $50,000.00 income · posted Oct 20, 2025

Official filing document

 Bills named in this filing 2
  • HR 3006
    To amend title XVIII of the Social Security Act to limit the coinsurance amount for certain services furnished in an am…
  • S 1776
    Medicare Beneficiary Co-Pay Fairness Act
 Lobbying activity 3
Medicare/Medicaid

Access and reimbursement of medical devices in Medicare program. Issues related to capping beneficiary copayments for Medicare beneficiaries in ambulatory surgery centers. Medicare Beneficiary Co-Pay Fairness Act of 2025 (H.R. 3006/S. 1776)

Health Issues

Issues related to Artificial Intelligences approval in Medical Devices.

Taxation/Internal Revenue Code

Issues related to corporate tax policy, including the corporate tax rate, R&D expensing, FDII extension, and implementation of the OECD global minimum tax (Pillar II).

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem